Cargando…

Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain

BACKGROUND: The influence of the stimulation frequency on the outcomes of dorsal root ganglion stimulation (DRG-S) to treat pain is not well understood. It is assumed that specific neural components dedicated to different tasks in the DRG can be preferably influenced at specific frequencies. The ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Piedade, G. S., Gillner, S., McPhillips, P. S., Vesper, J., Slotty, P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967770/
https://www.ncbi.nlm.nih.gov/pubmed/35217898
http://dx.doi.org/10.1007/s00701-022-05161-6
_version_ 1784678901759344640
author Piedade, G. S.
Gillner, S.
McPhillips, P. S.
Vesper, J.
Slotty, P. J.
author_facet Piedade, G. S.
Gillner, S.
McPhillips, P. S.
Vesper, J.
Slotty, P. J.
author_sort Piedade, G. S.
collection PubMed
description BACKGROUND: The influence of the stimulation frequency on the outcomes of dorsal root ganglion stimulation (DRG-S) to treat pain is not well understood. It is assumed that specific neural components dedicated to different tasks in the DRG can be preferably influenced at specific frequencies. The identification of frequencies designed for the type of pain and the ratio of neuropathic versus nociceptive pain might improve overall pain control and open new indications in DRG-S. METHOD: We report on a randomized double-blind clinical trial with a crossover design. Patients with a permanent DRG-S system underwent phases of stimulation with 20 Hz, 40 Hz, 60 Hz, 80 Hz, and sham in a randomized order. Each phase lasted for 4 days and was followed by a 2-day washout period. Pain intensity and quality of life were assessed with visual analog scale (VAS), McGill Pain Questionnaire (MPQ), EQ-5D, and Beck Depression Inventory (BDI). Analgesics intake was assessed. RESULTS: Overall 19 patients were included in the study. CRPS was the most frequent pain etiology (7). Five patients had a PainDetect score of 12 or lower at baseline. The mean VAS before the system was implanted was 8.6 and 3.9 at the baseline. Pain intensity was reduced to 3.7 by the stimulation with 20 Hz but increased with higher frequencies reaching 5.8 at 80 Hz. A significant difference among the groups was shown over all variables examined (VAS, MPQ, EQ-5D, BDI). The best results were seen at 20 Hz for all variables, including the smallest increase in pain medication consumption. CONCLUSIONS: The choice of the stimulation frequency shows a clear influence on pain reduction and quality of life. Lower stimulation frequencies seem to be most effective in neuropathic pain. Further studies are required to determine whether specific frequencies should be preferred based on the condition treated.
format Online
Article
Text
id pubmed-8967770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-89677702022-04-07 Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain Piedade, G. S. Gillner, S. McPhillips, P. S. Vesper, J. Slotty, P. J. Acta Neurochir (Wien) Original Article - Functional Neurosurgery - Pain BACKGROUND: The influence of the stimulation frequency on the outcomes of dorsal root ganglion stimulation (DRG-S) to treat pain is not well understood. It is assumed that specific neural components dedicated to different tasks in the DRG can be preferably influenced at specific frequencies. The identification of frequencies designed for the type of pain and the ratio of neuropathic versus nociceptive pain might improve overall pain control and open new indications in DRG-S. METHOD: We report on a randomized double-blind clinical trial with a crossover design. Patients with a permanent DRG-S system underwent phases of stimulation with 20 Hz, 40 Hz, 60 Hz, 80 Hz, and sham in a randomized order. Each phase lasted for 4 days and was followed by a 2-day washout period. Pain intensity and quality of life were assessed with visual analog scale (VAS), McGill Pain Questionnaire (MPQ), EQ-5D, and Beck Depression Inventory (BDI). Analgesics intake was assessed. RESULTS: Overall 19 patients were included in the study. CRPS was the most frequent pain etiology (7). Five patients had a PainDetect score of 12 or lower at baseline. The mean VAS before the system was implanted was 8.6 and 3.9 at the baseline. Pain intensity was reduced to 3.7 by the stimulation with 20 Hz but increased with higher frequencies reaching 5.8 at 80 Hz. A significant difference among the groups was shown over all variables examined (VAS, MPQ, EQ-5D, BDI). The best results were seen at 20 Hz for all variables, including the smallest increase in pain medication consumption. CONCLUSIONS: The choice of the stimulation frequency shows a clear influence on pain reduction and quality of life. Lower stimulation frequencies seem to be most effective in neuropathic pain. Further studies are required to determine whether specific frequencies should be preferred based on the condition treated. Springer Vienna 2022-02-26 2022 /pmc/articles/PMC8967770/ /pubmed/35217898 http://dx.doi.org/10.1007/s00701-022-05161-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article - Functional Neurosurgery - Pain
Piedade, G. S.
Gillner, S.
McPhillips, P. S.
Vesper, J.
Slotty, P. J.
Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title_full Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title_fullStr Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title_full_unstemmed Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title_short Frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
title_sort frequency dependency of therapeutic efficacy in dorsal root ganglion stimulation for neuropathic pain
topic Original Article - Functional Neurosurgery - Pain
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967770/
https://www.ncbi.nlm.nih.gov/pubmed/35217898
http://dx.doi.org/10.1007/s00701-022-05161-6
work_keys_str_mv AT piedadegs frequencydependencyoftherapeuticefficacyindorsalrootganglionstimulationforneuropathicpain
AT gillners frequencydependencyoftherapeuticefficacyindorsalrootganglionstimulationforneuropathicpain
AT mcphillipsps frequencydependencyoftherapeuticefficacyindorsalrootganglionstimulationforneuropathicpain
AT vesperj frequencydependencyoftherapeuticefficacyindorsalrootganglionstimulationforneuropathicpain
AT slottypj frequencydependencyoftherapeuticefficacyindorsalrootganglionstimulationforneuropathicpain